 | Union Health Minister launches first made-in-India intranasal Covid vaccineThe nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose. |
 | India's first intranasal Covid vaccine to be launched on Jan 26In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres. |
 | Germany to recognise Covaxin for travel purpose from June 1, says envoyIn November last year, the World Health Organisation recommended Emergency Use Listing (EUL) status for Covaxin. |
 | Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat BiotechWHO chief scientist Soumya Swaminathan had said that the global health body is likely to take a decision on Covaxin in the emergency use listing within four to six weeks. |
 | If everything goes well India would get COVID-19 vaccine by year-end: Harsh VardhanThree COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India. |
